A promising approach to treating insomnia involves targeting the orexin system, which regulates wakefulness. By blocking this system at night, patients may experience more naturalistic sleep, including improved REM stages. While the effectiveness of these newer drugs shows potential, their availability and insurance coverage remain significant barriers for many.
